Gynecomastia: Its features, and when and how to treat it
Shirley A. Bembo, MD
Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook
Harold E. Carlson, MD
Professor, Department of Medicine, and Head, Division of Endocrinology, Diabetes, and Metabolism, State University of New York at Stony Brook
Address: Shirley A. Bembo, MD, Division of Endocrinology and Metabolism, Health Sciences Center, T15 Room 060, Stony Brook University, Stony Brook, NY 11794-8154
This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTGynecomastia is common, being present in 30% to 50% of healthy men. A general medical history and careful physical examination with particular attention to features suggestive of breast cancer often suffice for evaluation in patients without symptoms or those with incidentally discovered breast enlargement. Men with recent-onset gynecomastia or mastodynia need a more detailed evaluation, including selected laboratory tests to search for an underlying cause. Treatment depends on the cause and may include observation, withdrawal of an offending drug, therapy of an underlying disease, giving androgen or antiestrogen drugs, or plastic surgery.